National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provide actionable information and analysis to healthcare organizations and payers across a range of mission-critical, constituent-related elements, including patient experience, satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement. The company offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. It also provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. The company offers transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, increase patient satisfaction and support safe care transitions; and risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs. It provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems and post-acute providers, such as home health, long term care, hospice, and payer organizations. The company was founded in 1981 and is headquartered in Lincoln, Nebraska.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Commercial physical research
Sub-IndustryHealth Care Services
SectorBusiness Services
Current SymbolNASDAQ:NRCIB
Previous Symbol
CUSIP63737230
Phone402-475-2525
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees458
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable
National Research (NASDAQ:NRCIB) Frequently Asked Questions
What is National Research's stock symbol?
National Research trades on the NASDAQ under the ticker symbol "NRCIB."
How often does National Research pay dividends? What is the dividend yield for National Research?
National Research declared a quarterly dividend on Tuesday, February 20th. Stockholders of record on Friday, March 30th will be paid a dividend of $0.60 per share on Friday, April 13th. This represents a $2.40 annualized dividend and a dividend yield of 4.53%. The ex-dividend date is Wednesday, March 28th. View National Research's Dividend History.
How were National Research's earnings last quarter?
National Research Co. (NASDAQ:NRCIB) posted its quarterly earnings results on Thursday, May, 4th. The business services provider reported $0.26 EPS for the quarter, missing the Zacks' consensus estimate of $0.81 by $0.55. The business services provider had revenue of $30.28 million for the quarter. View National Research's Earnings History.
Has National Research been receiving favorable news coverage?
News coverage about NRCIB stock has trended negative on Tuesday, InfoTrie reports. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. National Research earned a news sentiment score of -2.4 on InfoTrie's scale. They also assigned news coverage about the business services provider a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the next few days.
Who are some of National Research's key competitors?
Some companies that are related to National Research include Iqvia (IQV), Incyte (INCY), EXACT Sciences (EXAS), Icon (ICLR), PRA Health Sciences (PRAH), Charles River Laboratories Intl. (CRL), Exelixis (EXEL), Syneos Health (SYNH), BTG (BTGGF), Medpace (MEDP), Sorrento Therapeutics (SRNE), Pieris Pharmaceuticals (PIRS), Anavex Life Sciences (AVXL), Luna Innovations (LUNA) and Senomyx (SNMX).
Who are National Research's key executives?
National Research's management team includes the folowing people:
- Mr. Michael D. Hays, Founder, CEO & Director (Age 63)
- Mr. Steven D. Jackson, Pres (Age 42)
- Mr. Kevin R. Karas CPA, Principal Accounting Officer, Sr. VP of Fin., CFO, Treasurer & Sec. (Age 60)
- Ms. Helen Hrdy, Sr. VP of Client Services
How do I buy shares of National Research?
Shares of NRCIB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is National Research's stock price today?
One share of NRCIB stock can currently be purchased for approximately $53.0103.
What is National Research's official website?
How can I contact National Research?
National Research's mailing address is 1245 Q STREET, LINCOLN NE, 68508. The business services provider can be reached via phone at 402-475-2525.
MarketBeat Community Rating for National Research (NASDAQ NRCIB)
MarketBeat's community ratings are surveys of what our community members think about National Research and other stocks. Vote "Outperform" if you believe NRCIB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NRCIB will underperform the S&P 500 over the long term. You may vote once every thirty days.
